Current Neuro-Oncology

Volume 24 Number 13
15 July 2022

Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 13, 15 July

Kara B, Danyeli AE, Öztürk M, Ertan K, Köksal Y.
A pediatric bithalamic high grade glioma with concomitant H3K27M and EGFR mutations.
Turk J Pediatr. 2022 Jul-Aug;64(4):754-758∟. doi: 10.24953/turkjped.2021.1140∟. PMID: 36082650∟. Case report. ˍ

Bjorland LS, Dæhli Kurz K, Fluge Ø, Gilje B, Mahesparan R, Sætran H, Ushakova A, Farbu E.
Butterfly glioblastoma: Clinical characteristics, treatment strategies and outcomes in a population-based cohort.
Neurooncol Adv. 2022 Jul 1;4(1):vdac102∟. doi: 10.1093/noajnl/vdac102∟. PMID: 35892046∟. Observational study. ˍ

Lavanya G, Uppin MS, Alugolu R, Bhattacharjee S, Saradhi MV, Yeramneni VK.
Clinical Profile, Pathology, and Molecular Typing of Gliomas with Oligodendroglial Morphology: A Single Institutional Experience.
Neurol India. 2022 Jul 1;70(3):1020-1024∟. doi: 10.4103/0028-3886.349641? PMID: 35864633∟. Observational study. ˍ

Mishra N, Rath GP, Rajagopalan V, Doddamani R, Chaturvedi A.
Perioperative Management of Pediatric Brain Tumors: A Retrospective Analysis.
Neurol India. 2022 Jul 1;70(3):1095-1101∟. doi: 10.4103/0028-3886.349578? PMID: 35864645∟. Observational study. ˍ

Roelcke U, Schwyzer L, Zeitlberger AM, Hundsberger T.
Symptom burden in glioblastoma - a prospective pilot study from diagnosis to first progression.
Oncology. 2022 Jul 1∟. doi: 10.1159/000525651∟. PMID: 35780772∟. Interventional study˰ ˍ

Suzuki H, Ono T, Koyota S, Takahashi M, Sugai T, Nanjo H, Shimizu H.
Clinical, histopathological, and molecular features of IDH-wildtype indolent diffuse glioma: comparison with typical glioblastoma.
J Neurooncol. 2022 Jul 2∟. doi: 10.1007/s11060-022-04074-9∟. PMID: 35779193∟. Laboratory investigation˰ ˍ

Zhou H, Wu H, Li M, Dong C, Sun T.
Clinical efficacy of early postoperative intensity-modulated radiotherapy combined with Temozolomide chemotherapy in the treatment of patients with malignant glioma.
Pak J Med Sci. 2022 Jul 4;38(6):1460-1465∟. doi: 10.12669/pjms.38.6.5244∟. PMID: 35991249∟. Observational study. ˍ

Meister M, Lin JJ, Bach SE, Kapileshwarkar Y, Kumar P.
Medulloblastoma Presenting As Isolated Leptomeningeal Enhancement With No Primary Mass.
Cureus. 2022 Jul 5;14(7):e26598∟. doi: 10.7759/cureus.26598∟. PMID: 35936137∟. Case report. ˍ

Mansouri A, Lai C, Scales D, Pirouzmand F.
A phase II pilot randomized controlled trial to assess the feasibility of the "supra-marginal" surgical resection of malignant glioma (G-SUMIT: Glioma supra marginal incision trial) study protocol.
Pilot Feasibility Stud. 2022 Jul 5;8(1):138∟. doi: 10.1186/s40814-022-01104-1∟. PMID: 35791008∟. Interventional study Protocol. ˍ

Seystahl K, Oppong FB, Le Rhun E, Hertler C, Stupp R, Nabors B, Chinot O, Preusser M, Gorlia T, Weller M.
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma.
Neurooncol Adv. 2022 Jul 7;4(1):vdac112∟. doi: 10.1093/noajnl/vdac112∟. PMID: 35950086∟. Observational study. ˍ

Gonçalves FG, Tierradentro-Garcia LO, Kim JDU, Zandifar A, Ghosh A, Viaene AN, Khrichenko D, Andronikou S, Vossough A.
The role of apparent diffusion coefficient histogram metrics for differentiating pediatric medulloblastoma histological variants and molecular groups.
Pediatr Radiol. 2022 Jul 8∟. doi: 10.1007/s00247-022-05411-w∟. PMID: 35798974∟. Observational study˰ ˍ

*

Takeuchi H, Takahashi Y, Tanigawa S, Okamoto T, Kodama Y, Shishido-Hara Y, Yoshioka E, Shofuda T, Kanemura Y, Konishi E, Hashimoto N.
Genetic Alteration May Proceed with a Histological Change in Glioblastoma: A Report from Initially Diagnosed as Nontumor Lesion Cases.
NMC Case Rep J. 2022 Jul 8;9:199-208∟. doi: 10.2176/jns-nmc.2022-0038∟. PMID: 35974956∟. Case report. ˍ

Massimino M, Vennarini S, Barretta F, Colombo F, Antonelli M, Pollo B, Pignoli E, Pecori E, Alessandro O, Schiavello E, Boschetti L, Podda M, Puma N, Gattuso G, Sironi G, Barzanò E, Nigro O, Bergamaschi L, Chiaravalli S, Luksch R, Meazza C, Spreafico F, Terenziani M, Casanova M, Ferrari A, Chisari M, Pellegrini C, Clerici CA, Modena P, Biassoni V.
How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment.
J Neurooncol. 2022 Jul 9∟. doi: 10.1007/s11060-022-04079-4∟. PMID: 35809148∟. Observational study˰ ˍ

Liu R, Wei W, Hou H, Cong P, Zhou Y, Yu X.
Case Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation.
Onco Targets Ther. 2022 Jul 11;15:771-776∟. doi: 10.2147/OTT.S362185∟. PMID: 35847381∟. Case report. ˍ

Cole BL, Starr K, Lockwood CM, Leary SES.
The "SEED" Study: The Feasibility of Selecting Patient-Specific Biologically Targeted Therapy with Sorafenib, Everolimus, Erlotinib or Dasatinib for Pediatric and Young Adult Patients with Recurrent or Refractory Brain Tumors.
Front Biosci (Landmark Ed). 2022 Jul 12;27(7):219∟. doi: 10.31083/j.fbl2707219∟. PMID: 35866410∟. Interventional study. ˍ

Yang K, Ellenbogen Y, Martyniuk A, Sourour M, Takroni R, Somji M, Gardiner E, Hui K, Odedra D, Larrazabal R, Algird A, Kachur E, Reddy K, Murty N, Farrokhyar F, Singh SK.
Reoperation in adult patients with recurrent glioblastoma: A matched cohort analysis.
Neurooncol Adv. 2022 Jul 13;4(1):vdac115∟. doi: 10.1093/noajnl/vdac115∟. PMID: 35990706∟. Observational study. ˍ

*

Chen N, Alieva M, van der Most T, Klazen JAZ, Vollmann-Zwerenz A, Hau P, Vrisekoop N.
Neutrophils Promote Glioblastoma Tumor Cell Migration after Biopsy.
Cells. 2022 Jul 14;11(14):2196∟. doi: 10.3390/cells11142196∟. PMID: 35883641∟. Laboratory investigation. ˍ

García Vicente AM, Amo-Salas M, Sandoval Valencia H, Lozano Setien E, Soriano Castrejón ÁM.
Early Recurrence Detection of Glioma Using 18F-Fluorocholine PET/CT: GliReDe Pilot Study.
Clin Nucl Med. 2022 Jul 14∟. doi: 10.1097/RLU.0000000000004329∟. PMID: 35835092∟. Interventional study˰ ˍ

Saulnier Sholler G, Duda DG, Bergendahl G, Ebb D, Snuderl M, Laetsch TW, Michlitsch J, Hanson D, Isakoff MS, Bielamowicz K, Kraveka JM, Ferguson W, Carmeliet P, De Deene A, Gijsen L, Jain RK.
A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma.
Clin Cancer Res. 2022 Jul 14, 2022:ccr.22.1169∟. doi: 10.1158/1078-0432.CCR-22-1169∟. PMID: 35833850∟. Interventional study˰ ˍ

Harris L, Rahman S, Khoudir M, Low HL, Vaqas B.
Human Immunodeficiency Virus in Adults Undergoing Surgery for Brain Tumors.
Cureus. 2022 Jul 15;14(7):e26876∟. doi: 10.7759/cureus.26876∟. PMID: 35978755∟. Interventional study. ˍ

Lassman AB, Pugh SL, Wang TJC, Aldape K, Gan HK, Preusser M, Vogelbaum MA, Sulman EP, Won M, Zhang P, Moazami G, Macsai MS, Gilbert MR, Bain EE, Blot V, Ansell PJ, Samanta S, Kundu MG, Armstrong TS, Wefel JS, Seidel C, de Vos FY, Hsu S, Cardona AF, Lombardi G, Bentsion D, Peterson RA, Gedye C, Bourg V, Wick A, Curran WJ, Mehta MP.
Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial.
Neuro Oncol. 2022 Jul 15, 2022:noac173∟. doi: 10.1093/neuonc/noac173∟. PMID: 35849035∟. Interventional study. ˍ

Melnick KF, Miller P, Carmichael E, McGrath K, Ghiaseddin A, Tran DD, Rahman M.
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival.
J Neurooncol. 2022 Jul 15∟. doi: 10.1007/s11060-022-04083-8∟. PMID: 35840786∟. Observational study˰ ˍ

Takeda J, Nonaka M, Li Y, Isozaki H, Kamei T, Hashiba T, Asai A.
5-Aminolevulinic acid fluorescence-guided endoscopic surgery for intraventricular tumors.
Surg Neurol Int. 2022 Jul 15;13:302∟. doi: 10.25259/SNI_488_2022∟. PMID: 35928327∟. Observational study. ˍ